STANOZOLOL News
STANOZOLOL currently has 0 news articles, with 12 predicted indications.
This page combines the AI-predicted indications for STANOZOLOL with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Evidence level: L5
- Predicted indications (12):
- hereditary angioedema with C1Inh deficiency (99.0%)
- hereditary angioedema (99.0%)
- C1 inhibitor deficiency (100.0%)
- serpinopathy with toxic serpin polymerization (100.0%)
- fetal erythroblastosis (100.0%)
- Peyronie disease (100.0%)
- renal tubular acidosis (99.9%)
- immune-mediated necrotizing myopathy (99.8%)
- antisynthetase syndrome (99.8%)
- complement component C1s deficiency (99.8%)
- focal myositis (99.8%)
- inflammatory myopathy with abundant macrophages (99.8%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.